BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi YB, Li J, Lai XN, Jiang R, Zhao RC, Xiong LX. Multifaceted Roles of Caveolin-1 in Lung Cancer: A New Investigation Focused on Tumor Occurrence, Development and Therapy. Cancers (Basel) 2020;12:E291. [PMID: 31991790 DOI: 10.3390/cancers12020291] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Kasavi C. Potential biomarkers for lung adenocarcinoma identified by integrative transcriptomics analysis. Biotech Studies 2021;30:33-42. [DOI: 10.38042/biotechstudies.932937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Vilariño M, García-Sanmartín J, Ochoa-Callejero L, López-Rodríguez A, Blanco-Urgoiti J, Martínez A. Macrocybin, a Natural Mushroom Triglyceride, Reduces Tumor Growth In Vitro and In Vivo through Caveolin-Mediated Interference with the Actin Cytoskeleton. Molecules 2020;25:E6010. [PMID: 33353176 DOI: 10.3390/molecules25246010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ye JH, Shi JJ, Yin X, Wu HY, Xu XY, Yao YZ, Zhang WJ. Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant Chemotherapy. Cancer Manag Res 2020;12:8887-92. [PMID: 33061584 DOI: 10.2147/CMAR.S264673] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yu L, Hua Z, Luo X, Zhao T, Liu Y. Systematic interaction of plasma albumin with the efficacy of chemotherapeutic drugs. Biochim Biophys Acta Rev Cancer 2021;1877:188655. [PMID: 34780933 DOI: 10.1016/j.bbcan.2021.188655] [Reference Citation Analysis]
5 Qi H, Liu Y, Wang N, Xiao C. Lentinan Attenuated the PM2.5 Exposure-Induced Inflammatory Response, Epithelial-Mesenchymal Transition and Migration by Inhibiting the PVT1/miR-199a-5p/caveolin1 Pathway in Lung Cancer. DNA Cell Biol 2021;40:683-93. [PMID: 33902331 DOI: 10.1089/dna.2020.6338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yang L, Wu H, Zhu Y, Chen X, Chen Y. Plasma exosomal caveolin-1 predicts Poor Prognosis in Ovarian Cancer. J Cancer 2021;12:5005-12. [PMID: 34234869 DOI: 10.7150/jca.58762] [Reference Citation Analysis]
7 Takahashi S, Asada K, Takasawa K, Shimoyama R, Sakai A, Bolatkan A, Shinkai N, Kobayashi K, Komatsu M, Kaneko S, Sese J, Hamamoto R. Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data. Biomolecules 2020;10:E1460. [PMID: 33086649 DOI: 10.3390/biom10101460] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
8 Song Y, Du Y, Qin C, Liang H, Yang W, Lin J, Ding M, Han J, Xu T. Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment. Front Cell Dev Biol 2022;9:809620. [DOI: 10.3389/fcell.2021.809620] [Reference Citation Analysis]
9 Wang Z, Li X, Chen H, Han L, Ji X, Wang Q, Wei L, Miao Y, Wang J, Mao J, Zhang Z. Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma. Med Sci Monit 2021;27:e929333. [PMID: 33979320 DOI: 10.12659/MSM.929333] [Reference Citation Analysis]
10 Liu Q, Wang Y, Duan M, Fan Y, Pan X, Liu S, Yu Q, Huang L, Zhou F. Females and Males Show Differences in Early-Stage Transcriptomic Biomarkers of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Diagnostics (Basel) 2021;11:347. [PMID: 33669819 DOI: 10.3390/diagnostics11020347] [Reference Citation Analysis]